Uv Ayurgen Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.00 M
- Revenue Growth -29.61%
- Profit Growth -70.73%
- Ebitda -29.11%
- Net Worth 14.92%
- Total Assets -12.35%
About Uv Ayurgen Pharma
Uv Ayurgen Pharma Private Limited. (UAPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 July 2008 and has a history of 16 years and six months. Its registered office is in Satara, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹3.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Rajiv Puranik and Parikshit Bhide serve as directors at the Company.
Company Details
-
Location
Satara, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110PN2008PTC132511
-
Company No.
132511
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Jul 2008
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Uv Ayurgen Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Puranik
|
Director | 01-Jul-2023 | Current |
|
Parikshit Bhide
|
Director | 01-Jul-2023 | Current |
Financial Performance of Uv Ayurgen Pharma.
Uv Ayurgen Pharma Private Limited., for the financial year ended 2020, experienced significant reduction in revenue, with a 29.61% decrease. The company also saw a substantial fall in profitability, with a 70.73% decrease in profit. The company's net worth Soared by an impressive increase of 14.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uv Ayurgen Pharma?
In 2020, Uv Ayurgen Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Dynamic Remedies Pvt LtdRajiv Puranik is a mutual person
Charges (Loans)
₹0
₹3.00 M
Charges Breakdown by Lending Institutions
- Bank Of Maharashtra : 0.30 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Mar 2012 | Bank Of Maharashtra | ₹3.00 M | Satisfied |
How Many Employees Work at Uv Ayurgen Pharma?
Uv Ayurgen Pharma has a workforce of 22 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uv Ayurgen Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uv Ayurgen Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
